Cargando…
Tumor suppressing effects of tristetraprolin and its small double‐stranded RNAs in bladder cancer
Bladder cancer (BCa) is a common malignant tumor of urinary system with few treatments, so more useful therapeutic targets are still needed. Antitumor effects of tristetraprolin (TTP) have been explored in many type tumors, but its roles in bladder cancer are still unknown until now. In this study,...
Autores principales: | Jiang, Wen, Zhu, Dandan, Wang, Chenghe, Zhu, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826468/ https://www.ncbi.nlm.nih.gov/pubmed/33259133 http://dx.doi.org/10.1002/cam4.3622 |
Ejemplares similares
-
An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)
por: Jiang, Wen, et al.
Publicado: (2020) -
Overexpression of TNKS1BP1 in lung cancers and its involvement in homologous recombination pathway of DNA double‐strand breaks
por: Tan, Wei, et al.
Publicado: (2017) -
A novel hedgehog inhibitor iG2 suppresses tumorigenesis by impairing self‐renewal in human bladder cancer
por: Zhu, Lihong, et al.
Publicado: (2016) -
HUWE1 controls tristetraprolin proteasomal degradation by regulating its phosphorylation
por: Scinicariello, Sara, et al.
Publicado: (2023) -
At the double for tumor suppressor
por: Sonawane, Mahendra
Publicado: (2016)